Medication info

Moavita Injection

Prescription medicationInjections
Ingredient · strength
L-Lysine Hydrochloride›300mg / 100mLL-Leucine›240mg / 100mLL-Isoleucine›150mg / 100mLL-Methionine›240mg / 100mLL-Phenylalanine›240mg / 100mLL-Threonine›120mg / 100mLL-Tryptophan›60mg / 100mLL-Valine›200mg / 100mLL-Alanine›1200mg / 100mLL-Arginine›400mg / 100mLL-Histidine Hydrochloride Hydrate›200mg / 100mLL-Proline›350mg / 100mLGlycine›1200mg / 100mLL-Ornithine-L-Aspartate›93.6mg / 100mLD-Sorbitol›10000mg / 100mLPyridoxine Hydrochloride›8mg / 100mLNicotinamide›6mg / 100mLRiboflavin Sodium Phosphate›1mg / 100mL
Manufacturer / importer
Hanol BioPharma Co., Ltd.
Appearance
The product is a yellow transparent aqueous injection.
Packaging
For internal use - 500 milliliters/bag, for internal use - 250 milliliters/bag
Approval status
Active

MFDS item code 198000154 · Notified 1980.09.18

Summary

Main use
Nutritional improvement through amino acid supplementation (hypoproteinemia, malnutrition, etc.)
Who uses it
Adults · Children
Adult dosage
○Adults: Administer by intravenous infusion, up to a maximum dose of 1~1.5 g of total amino acids per kg of body weight per day. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred, and the general principle is to infuse at a rate of 80~130 drops per minute. However, the maximum daily dose is 100g as D-sorbitol.
Children's dosage
For children, older adults, and patients with burns who have high protein requirements, adjust the dose and infusion rate before administration.

Ingredients

Manufacturer
Hanol BioPharma Co., Ltd.

Efficacy & effects

Nutritional improvement through amino acid supplementation (hypoproteinemia, malnutrition, etc.)

  • Hypoproteinemia
  • malnutrition
View approved original text

Amino acid supply is necessary in cases of hypoproteinemia, malnutrition, and conditions such as pre- and post-surgery. Providing amino acids in such situations helps improve nutritional status, aids recovery, and promotes protein metabolism. Therefore, this medicine is used for hypoproteinemia, malnutrition, and recovery before and after surgery.

Dosage and Administration

Adult dosage

○Adults: Administer by intravenous infusion, up to a maximum dose of 1~1.5 g of total amino acids per kg of body weight per day. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred, and the general principle is to infuse at a rate of 80~130 drops per minute. However, the maximum daily dose is 100g as D-sorbitol.

Children's dosage

For children, older adults, and patients with burns who have high protein requirements, adjust the dose and infusion rate before administration.

Precautions

This medicine must be used under the direction of a physician. It should not be used in patients with hepatic coma or at risk of hepatic coma, those with severe renal impairment, and patients with certain metabolic disorders. Patients with congestive heart failure, pulmonary edema, oliguria, anuria, hypernatremia, hyperchloremia, or alkalosis should also avoid this medication. In cases where specific components are included, it should be avoided in patients with lactic acidosis, methyl alcohol poisoning, or hereditary fructose intolerance. Caution is also required for patients with heart-related diseases or those with AV block and myasthenia gravis. This medicine should be administered carefully in patients with severe acidosis, congestive heart failure, edema due to sodium retention, hyperkalemia, diabetes insipidus, liver dysfunction, and renal dysfunction. Allergic reactions or asthma attacks may occur due to components in this medication, especially in asthma patients. When using this medication, various side effects such as rash, nausea, vomiting, palpitations, and increased blood pressure may occur; therefore, it should be discontinued immediately if any abnormal symptoms appear. Rapid high-dose administration may lead to acidosis; caution is needed. Patients with reduced liver and kidney function may have elevated specific blood levels, so regular testing is necessary. To prevent electrolyte imbalance, electrolyte status should be thoroughly checked during high-dose administration, and diabetic patients should frequently monitor blood glucose levels. Interactions may occur when used with other medications, so consultation with healthcare professionals is required. Pregnant women should only use this medication under a physician's judgment since its safety has not been established. In children, liver function may be immature, thus the infusion concentration should be kept low, and blood ammonia levels should be frequently monitored. Elderly patients may have reduced physical functions, so administration should be done slowly, and dosages should be adjusted. This medication contains electrolytes and can cause side effects if infused rapidly, thus it should be slowly infused intravenously. Maintain sterile conditions during administration to reduce infection risks, and do not use if the product is discolored or damaged. While storing, keep the packaging until opened, and properly handle softbag or vial products. The patient's condition should be closely monitored throughout the administration of this medication, and immediate action should be taken in case of adverse reactions.

Side effects

  • rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • tachycardia
  • increased blood pressure
  • acidosis
  • warmth
  • vascular pain
Show 29 more
  • chills
  • fever
  • headache
  • respiratory distress
  • respiratory arrest
  • shock
  • bronchospasm
  • ureteral spasm
  • peripheral vascular dilation
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • generalized nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress, preferably at room temperature between 1 and 30 degrees Celsius. This will help maintain the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

The product is a yellow transparent aqueous injection.

Package unit

For internal use - 500 milliliters/bag, for internal use - 250 milliliters/bag

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.